Effect and safety of tamsulosin, the prostate specific alpha(1)-blocker, in the treatment of BPH (benign prostatic hyperplasia)

被引：2
|
作者：
Kawabe, K
机构：
[1] Department of Urology, Faculty of Medicine, The University of Tokyo, Tokyo
来源：
AKTUELLE UROLOGIE | 1996年 / 27卷
关键词：
BPH; alpha-blocker; alpha(1a)-receptor-subtype; tamsulosin;
D O I：
10.1055/s-2008-1055642
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
Clinical trials of tamsulosin demonstrate that it is an effective treatment modality for the symptoms associated with BPH, and it has practically no effect on blood pressure at a dose of 0.2 mg. This is probably due to its selective affinity for the prostate, which may be due to the strong affinity of tamsulosin for the alpha(1a)-receptor subtype.
引用
收藏
页码：25 / 26
页数：2
相关论文
共 50 条
  • [1] EFFICACY AND SAFETY OF TAMSULOSIN IN THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA
    KAWABE, K
    BRITISH JOURNAL OF UROLOGY, 1995, 76 : 63 - 67
  • [2] Efficacy and safety of tamsulosin for the treatment of benign prostatic hyperplasia: a meta analysis
    Ren Rui-min
    Kou Min
    Lan Xiao-xu
    CHINESE MEDICAL JOURNAL, 2010, 123 (02) : 234 - 238
  • [3] Population PKS & PDS of tamsulosin, in patients with benign prostatic hyperplasia (BPH)
    Forrest, A
    Collins, DA
    Shore, RM
    Rubino, CM
    Yasukawa, K
    Tajima, Y
    Ito, Y
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1996, 59 (02) : PI98 - PI98
  • [4] Tamsulosin and chlormadinone for the treatment of benign prostatic hyperplasia
    Okada, H
    Kawaida, N
    Ogawa, T
    Arakawa, S
    Matsumoto, O
    Kamidono, S
    SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 1996, 30 (05): : 379 - 385
  • [5] Tamsulosin: The first prostate-selective alpha(1A)-adrenoceptor antagonist for the treatment of symptomatic benign prostatic hyperplasia
    Rabasseda, X
    Fitzpatrick, JM
    DRUGS OF TODAY, 1996, 32 (03): : 259 - 268
  • [6] OUR EXPERIENCE WITH THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA (BPH) WITH TAMSULOSIN IN PATIENTS WITH NORMOTENSION OR ORTHOSTATIC HYPOTENSION
    Saidi, S.
    Stankov, O.
    Dohcev, S.
    Stavridis, S.
    Mickovski, A.
    Penev, M.
    Shabani, B.
    Ivanovski, O.
    Popov, Z.
    EUROPEAN UROLOGY SUPPLEMENTS, 2010, 9 (06) : 598 - 598
  • [7] EFFICACY AND SAFETY OF THE ALPHA-1 BLOCKER DOXAZOSIN IN THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA - ANALYSIS OF 5 STUDIES
    JANKNEGT, RA
    CHAPPLE, CR
    EUROPEAN UROLOGY, 1993, 24 (03) : 319 - 326
  • [8] BIFLURANOL IN THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA (BPH)
    BEACOCK, CJM
    BUCK, AC
    ROBERTS, EE
    PROSTATE, 1985, 7 (04): : 357 - 361
  • [9] BENIGN PROSTATIC HYPERPLASIA (BPH) - DIAGNOSIS AND TREATMENT
    CLINTON, JJ
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 271 (15): : 1151 - 1151
  • [10] ALPHA-BLOCKADE FOR BENIGN PROSTATIC HYPERPLASIA (BPH)
    LEPOR, H
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (03): : 750 - 753
12345